Literature DB >> 21036067

Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS).

Melanie D Everitt1, Amy E Donaldson, Josef Stehlik, Aditya K Kaza, Deborah Budge, Rami Alharethi, Emily A Bullock, Abdallah G Kfoury, Anji T Yetman.   

Abstract

BACKGROUND: Patients with congenital heart disease (CHD) now survive into adulthood and often present with end-stage heart failure (HF). HF management and approach to orthotopic heart transplant (OHT) may differ from adults without CHD. We sought to compare OHT waitlist characteristics and outcomes for these 2 groups.
METHODS: The Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) database was used to identify adults (≥18 years) listed for OHT from 2005 to 2009. The cohort was divided into those with or without CHD.
RESULTS: Of 9,722 adults included, 314 (3%) had CHD. Adults with CHD were younger (35 ± 13 vs 52 ± 12 years, p < 0.01) and more often had undergone prior cardiac surgery (85% vs. 34%, p < 0.01). Patients with CHD were less likely to have a defibrillator (44% vs 75%, p < 0.01) or ventricular assist device (5% vs 14%, p < 0.01) and were more likely to be listed at the lowest urgency status than patients without CHD (64% vs 44%, p < 0.01). Fewer CHD patients achieved OHT (53% vs 65%, p < 0.001). Although overall waitlist mortality did not differ between groups (10% vs 8%, p = 0.15), patients with CHD were more likely to experience cardiovascular death (60% vs 40%, p = 0.03), including sudden in 44% and due to HF in 16%.
CONCLUSIONS: Despite lower urgency status, patients with CHD have greater cardiovascular mortality awaiting OHT than those without. Increased defibrillator use could improve survival to OHT, because sudden death is common. VAD support may benefit select patients, but experience in CHD is limited. Referral to specialized adult congenital heart centers can enhance utilization of device therapies and potentially improve waitlist outcomes.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21036067     DOI: 10.1016/j.healun.2010.09.008

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  20 in total

1.  Heart failure in adult congenital heart disease.

Authors:  Ada Stefanescu; Doreen DeFaria Yeh; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

Review 2.  Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease.

Authors:  John D Serfas; Priyesh A Patel; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2018-08-09       Impact factor: 2.931

3.  Transplantation in the single ventricle population.

Authors:  Louise A Kenny; Fabrizio DeRita; Mohamed Nassar; John Dark; Louise Coats; Asif Hasan
Journal:  Ann Cardiothorac Surg       Date:  2018-01

4.  Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease?

Authors:  Eileen M Hsich; Joseph G Rogers; Dennis M McNamara; David O Taylor; Randall C Starling; Eugene H Blackstone; Jesse D Schold
Journal:  JACC Heart Fail       Date:  2016-05-11       Impact factor: 12.035

Review 5.  Transplant and mechanical circulatory support in patients with adult congenital heart disease.

Authors:  James Monaco; Amber Khanna; Prateeti Khazanie
Journal:  Heart Fail Rev       Date:  2020-07       Impact factor: 4.214

6.  Critical care management of the adult patient with congenital heart disease: focus on postoperative management and outcomes.

Authors:  Nathalie Roy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-02

Review 7.  Heart transplantation for adults with congenital heart disease: current status and future prospects.

Authors:  Hikaru Matsuda; Hajime Ichikawa; Takayoshi Ueno; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-04-24

8.  Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices.

Authors:  Jill M Gelow; Howard K Song; Joseph B Weiss; James O Mudd; Craig S Broberg
Journal:  J Heart Lung Transplant       Date:  2013-08-06       Impact factor: 10.247

Review 9.  An overview of mechanical circulatory support in single-ventricle patients.

Authors:  Jacob R Miller; Timothy S Lancaster; Connor Callahan; Aaron M Abarbanell; Pirooz Eghtesady
Journal:  Transl Pediatr       Date:  2018-04

10.  The total artificial heart in patients with congenital heart disease.

Authors:  Karthik Thangappan; Awais Ashfaq; Chet Villa; David L S Morales
Journal:  Ann Cardiothorac Surg       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.